Tompkins Tamara 4
4 · Unity Biotechnology, Inc. · Filed Sep 23, 2019
Insider Transaction Report
Form 4
Tompkins Tamara
Corporate Secretary and GC
Transactions
- Award
Stock Option (Right to Buy)
2019-09-19+19,068→ 19,068 totalExercise: $3.40From: 2019-09-19Exp: 2027-07-26→ Common Stock (19,068 underlying)
Holdings
- 21,075
Common Stock, $0.0001 par value
Footnotes (2)
- [F1]Includes Restricted Stock Units which vest over time measured from the grant date.
- [F2]On July 26, 2017, Reporting Person was granted an option exercisable for 76,271 shares. Twenty-five percent (25%) of the shares was subject to vesting pursuant to the achievement of a clinical development milestone; in this case proof of concept that treatment with a senolytic drug meaningfully ameliorates a human disease. On September 19, 2019, Issuer's Board of Directors determined that such milestone was achieved.